Skip to main content
TipRanks
Go Ultimate75% OFF

Iovance Biotherapeutics (0JDK) Ratios

5 Followers

Iovance Biotherapeutics Ratios

GB:0JDK's free cash flow for Q3 2026 was $-9.21M. For the 2026 fiscal year, GB:0JDK's free cash flow was decreased by $-4.74M and operating cash flow was $-4.47M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio3.203.742.795.245.69
Quick Ratio2.833.312.705.245.69
Cash Ratio1.180.951.042.530.88
Solvency Ratio-1.60-1.64-2.10-2.28-2.11
Operating Cash Flow Ratio-2.19-2.89-3.28-3.20-2.56
Short-Term Operating Cash Flow Coverage-74.800.000.000.000.00
Net Current Asset Value$ 228.10M$ 257.00M$ 112.11M$ 314.77M$ 352.28M
Leverage Ratios
Debt-to-Assets Ratio0.050.060.100.130.09
Debt-to-Equity Ratio0.070.080.130.170.12
Debt-to-Capital Ratio0.060.080.110.150.10
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.311.281.331.331.25
Debt Service Coverage Ratio-86.280.000.00-126.550.00
Interest Coverage Ratio0.000.000.00-133.630.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.140.200.320.560.47
Net Debt to EBITDA0.330.170.090.390.02
Profitability Margins
Gross Profit Margin34.28%24.43%-804.54%0.00%0.00%
EBIT Margin-151.12%-228.56%-38734.99%0.00%0.00%
EBITDA Margin-133.16%-201.99%-35948.86%0.00%0.00%
Operating Profit Margin-151.12%-240.92%-38734.99%0.00%0.00%
Pretax Profit Margin-149.16%-228.56%-37638.02%0.00%0.00%
Net Profit Margin-148.38%-226.84%-37345.42%0.00%0.00%
Continuous Operations Profit Margin-148.38%-226.84%-37345.42%0.00%0.00%
Net Income Per EBT99.47%99.25%99.22%100.00%100.00%
EBT Per EBIT98.70%94.87%97.17%99.25%99.87%
Return on Assets (ROA)-42.82%-40.88%-56.90%-59.62%-44.03%
Return on Equity (ROE)-55.97%-52.39%-75.95%-79.24%-55.05%
Return on Capital Employed (ROCE)-51.39%-50.16%-68.74%-69.67%-49.80%
Return on Invested Capital (ROIC)-50.86%-48.98%-67.42%-68.17%-49.44%
Return on Tangible Assets-61.68%-59.26%-80.57%-59.62%-44.03%
Earnings Yield-40.08%-17.35%-23.23%-38.90%-11.69%
Efficiency Ratios
Receivables Turnover3.202.377.870.000.00
Payables Turnover7.824.510.320.000.00
Inventory Turnover3.352.411.040.000.00
Fixed Asset Turnover1.491.000.010.000.00
Asset Turnover0.290.180.000.000.00
Working Capital Turnover Ratio0.820.620.000.000.00
Cash Conversion Cycle176.42224.94-725.760.000.00
Days of Sales Outstanding114.21154.2646.350.000.00
Days of Inventory Outstanding108.92151.66352.000.000.00
Days of Payables Outstanding46.7080.981124.120.000.00
Operating Cycle223.12305.92398.360.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.85-1.22-1.54-1.84-1.49
Free Cash Flow Per Share-0.94-1.26-1.63-1.97-1.73
Dividend Paid and CapEx Coverage Ratio-8.94-31.89-16.23-14.33-6.07
Capital Expenditure Coverage Ratio-8.94-31.89-16.23-14.33-6.07
Operating Cash Flow Coverage Ratio-6.24-6.06-4.77-3.43-3.19
Operating Cash Flow to Sales Ratio-1.15-2.15-304.310.000.00
Free Cash Flow Yield-34.47%-16.97%-20.09%-30.77%-9.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-2.50-5.78-4.31-2.57-8.56
Price-to-Sales (P/S) Ratio3.7013.071607.750.000.00
Price-to-Book (P/B) Ratio1.403.023.272.044.71
Price-to-Free Cash Flow (P/FCF) Ratio-2.90-5.89-4.98-3.25-11.03
Price-to-Operating Cash Flow Ratio-3.23-6.08-5.28-3.48-12.85
Price-to-Earnings Growth (PEG) Ratio0.170.180.18-0.22-0.46
Enterprise Value Multiple-2.45-6.30-4.38-2.31-8.89
Enterprise Value860.92M2.09B1.87B871.38M2.92B
EV to EBITDA-2.45-6.30-4.38-2.31-8.89
EV to Sales3.2712.721574.930.000.00
EV to Free Cash Flow-2.56-5.73-4.88-2.78-11.00
EV to Operating Cash Flow-2.85-5.91-5.18-2.98-12.82
Tangible Book Value Per Share1.171.481.513.144.05
Shareholders’ Equity Per Share1.952.452.493.144.05
Tax and Other Ratios
Effective Tax Rate0.010.010.010.000.00
Revenue Per Share0.740.570.010.000.00
Net Income Per Share-1.09-1.28-1.89-2.49-2.23
Tax Burden0.990.990.991.001.00
Interest Burden0.991.000.970.991.00
Research & Development to Revenue1.141.72289.380.000.00
SG&A to Revenue0.580.930.000.000.00
Stock-Based Compensation to Revenue0.230.6752.670.000.00
Income Quality0.770.950.810.740.67

Currency in USD